Who
Sara Kenkare-Mitra
Director
Company insider
Files Form 4 as: Director, Unicycive Therapeutics; President and Head of R&D, Alector.
In numbers
- Trades disclosed
- 34
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $663K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 3 Jan 2022
- Last trade
- 14 May 2026
- Last filed
- 28 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 28 Jul 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,941 at $0.00 | filing |
| 14 May 2026filed 28 Jul 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,941 at $0.00 | filing |
| 14 May 2026filed 15 Jun 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,200 at $0.00 | filing |
| 14 May 2026filed 15 Jun 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,100 at $0.00 | filing |
| 14 May 2026filed 15 Jun 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,200 at $0.00 | filing |
| 14 May 2026filed 15 Jun 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,100 at $0.00 | filing |
| 14 May 2026filed 21 May 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,200 at $0.00 | filing |
| 14 May 2026filed 21 May 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,100 at $0.00 | filing |
| 14 May 2026filed 21 May 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,200 at $0.00 | filing |
| 14 May 2026filed 21 May 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,100 at $0.00 | filing |
| 3 Dec 2025filed 3 Dec 2025 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $47K41,687 at $1.12 | filing |
| 2 Sep 2025filed 4 Sep 2025 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $59K23,638 at $2.50 | filing |
| 28 Jul 2025filed 30 Jul 2025 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,200 at $0.00 | filing |
| 1 Jul 2025filed 1 Jul 2025 | ALEC Alectoroption or derivative · Biotechnology | SEC FORM 4 Code A | —18,250 at $0.00 | filing |
| 1 Jul 2025filed 1 Jul 2025 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —54,725 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $32K23,890 at $1.34 | filing |
| 3 Mar 2025filed 5 Mar 2025 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $43K29,073 at $1.47 | filing |
| 2 Dec 2024filed 3 Dec 2024 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $67K26,500 at $2.52 | filing |
| 1 Oct 2024filed 2 Oct 2024 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 3 Sep 2024filed 4 Sep 2024 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $68K13,926 at $4.88 | filing |
News
Alector (NASDAQ: ALEC) prices shares at a 7.3% premium in stock saleALEC · dailypolitical.com · 18 Oct 2026Alector Maps Brain-Delivery Pipeline for Alzheimer's, Parkinson's TherapiesALEC · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Sara Kenkare-Mitra; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.